Chronic steroid use as a risk factor for postoperative complications following arthroscopic rotator cuff repair

© 2023 The Author(s).

Bibliographische Detailangaben
Veröffentlicht in:JSES international. - 2020. - 7(2023), 5 vom: 20. Sept., Seite 780-785
1. Verfasser: Fassler, Richelle (VerfasserIn)
Weitere Verfasser: Ling, Kenny, Tantone, Ryan, Komatsu, David E, Wang, Edward D
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:JSES international
Schlagworte:Journal Article Arthroscopic rotator cuff repair Immunosuppressants Mortality Postoperative complications Shoulder Steroids
LEADER 01000naa a22002652 4500
001 NLM362166951
003 DE-627
005 20231226090657.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jseint.2023.05.015  |2 doi 
028 5 2 |a pubmed24n1207.xml 
035 |a (DE-627)NLM362166951 
035 |a (NLM)37719824 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Fassler, Richelle  |e verfasserin  |4 aut 
245 1 0 |a Chronic steroid use as a risk factor for postoperative complications following arthroscopic rotator cuff repair 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 20.09.2023 
500 |a published: Electronic-eCollection 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a © 2023 The Author(s). 
520 |a Background: Steroids are a common treatment for many rheumatologic and inflammatory disorders. Chronic steroid use has been studied in joint arthroplasty and arthroscopy, but studies specifically on preoperative chronic steroid use in arthroscopic rotator cuff repair (aRCR) are limited. The purpose of this study is to determine the association between chronic steroid use and 30-day postoperative outcomes following aRCR 
520 |a Methods: The American College of Surgeons National Surgical Quality Improvement Program (NSQIP) was queried to identify all patients who underwent aRCR between 2015 and 2020. Patients were divided into 2 cohorts: nonsteroid users and chronic steroid users. Univariate binomial regression analysis was used to compare demographics, comorbidities, and postoperative outcomes between cohorts. Multivariate regression analysis, adjusted for all significant demographics and comorbidities, was used to identify significant 30-day postoperative outcomes 
520 |a Results: A total of 39,876 patients remained after exclusion criteria, with 39,068 (97.97%) in the nonsteroid group and 808 (2.02%) in the chronic steroid group. Patient demographics and comorbidities significantly associated with chronic steroid use were age ≥65 (P < .001), female gender (P < .001), body mass index (BMI) ≥35, American Society of Anesthesiologists (ASA) ≥3 (P < .001), dependent functional status (P < .001), nonsmokers (P = .046), higher rates of dyspnea (P < .001), chronic obstructive pulmonary disease (COPD) (P < .001), congestive heart failure (P < .001), hypertension requiring medication (P < .001), open wound infection (P = .018), unintentional weight loss (P < .001), bleeding disorders (P < .001), and inpatient procedure (P = .013). Multivariate analysis found preoperative chronic steroid use to be an independent predictor of mortality within 30 days following aRCR (OR 8.15, confidence interval (CI) 1.45-45.86; P = .017) 
520 |a Conclusion: Chronic steroid use was not found to be an independent risk factor for infection, readmission, or reoperation following aRCR. It was, however, found to be independently associated with higher rates of 30-day mortality following aRCR, although with a limited overall number of deaths reported 
650 4 |a Journal Article 
650 4 |a Arthroscopic rotator cuff repair 
650 4 |a Immunosuppressants 
650 4 |a Mortality 
650 4 |a Postoperative complications 
650 4 |a Shoulder 
650 4 |a Steroids 
700 1 |a Ling, Kenny  |e verfasserin  |4 aut 
700 1 |a Tantone, Ryan  |e verfasserin  |4 aut 
700 1 |a Komatsu, David E  |e verfasserin  |4 aut 
700 1 |a Wang, Edward D  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t JSES international  |d 2020  |g 7(2023), 5 vom: 20. Sept., Seite 780-785  |w (DE-627)NLM307818438  |x 2666-6383  |7 nnns 
773 1 8 |g volume:7  |g year:2023  |g number:5  |g day:20  |g month:09  |g pages:780-785 
856 4 0 |u http://dx.doi.org/10.1016/j.jseint.2023.05.015  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_50 
912 |a GBV_ILN_65 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 7  |j 2023  |e 5  |b 20  |c 09  |h 780-785